SBI Securities
VERA icon

SBI Securities’s Vera Therapeutics VERA Stock Holding History

SBI Securities’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$226 Buy
7
+5
+250% +$175 ﹤0.01% 3374
2026
Q2 		$86 Buy
2
+1
+100% +$37 ﹤0.01% 3543
2026
Q1 		$40 Sell
1
-1
-50% -$43 ﹤0.01% 3622
2025
Q4 		$101 Hold
2
– – ﹤0.01% 3400
2025
Q3 		$58 Sell
2
-105
-98% -$2.43K ﹤0.01% 3669
2025
Q2 		$2.52K Buy
107
+106
+10,600% +$2.38K ﹤0.01% 2289
2025
Q1 		$24 Hold
1
– – ﹤0.01% 3820
2024
Q4 		$42 Buy
+1
New +$44 ﹤0.01% 3678

Other funds holding VERA

E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
MFA Wealth Advisors
MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

SBI Securities's VERA Position: Q3 2026 in Review

SBI Securities increased its Vera Therapeutics (VERA) stake by 250% in Q3 2026, buying an estimated $175 and bringing the position to 7 shares worth $226. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

SBI Securities first reported a position in VERA in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.52K in Q2 2025. 19 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • SBI Securities held 7 shares of Vera Therapeutics worth $226 as of Q3 2026.
  • SBI Securities bought 5 Vera Therapeutics shares in Q3 2026, an estimated $175.
  • Vera Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3374 holding.
  • SBI Securities first reported a position in Vera Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Vera Therapeutics position peaked at $2.52K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.